¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fibrin polymer"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® fibrin ÇÑ±Û ¼¶À¯¼Ò
¼³¸í   
  Çǰ¡ ±»À» ¶§ ¼¶À¯¼Ò¿¡ Æ®·ÒºóÀÌ ÀÛ¿ëÇÏ¿© »ý±â´Â ¼¶À¯ °°Àº ´Ü¹éÁú. ¹«»öÀ̳ª ¿¯Àº È²»öÀ» ¶í °íü·Î, ¹°¿¡ Àß ³ìÁö ¾ÊÀ¸¸ç Ç÷±¸¿Í ¾ûŰ¾î ÇǸ¦ ±»°Ô ÇÏ¿© ÃâÇ÷À» ±×Ä¡°Ô ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrin
    ¼¶À¯¼Ò, ÇǺ기
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°, ÇǺ기ºÐÇØ»ê¹°
  • fibrin stabilizing factor
    ¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ
  • fibrin thrombus
    ¼¶À¯¼ÒÇ÷Àü, ÇǺ기Ç÷Àü
  • myogen fibrin
    ¹Ì¿À°Õ¼¶À¯¼Ò
  • addition polymer
    ºÎ°¡ÁßÇÕü
  • bioadhesive polymer
    »ýü°áÇÕ¼ºÁßÇÕü
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ
  • hydration polymer
    ¼öÈ­ÁßÇÕü
  • polymer
    秂͟
  • polymer molecule
    ÁßÇÕüºÐÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrin
    ¼¶À¯¼Ò
  • polymer
    秂͟
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrin
    ¼¶À¯¼Ò
  • fibrin thrombus
    ¼¶À¯¼ÒÇ÷Àü
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • fibrin stabilizing factor
    ¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ
  • myogen fibrin
    ¹Ì¿À°Õ¼¶À¯¼Ò
  • addition polymer
    ºÎ°¡ÁßÇÕ¹°
  • bioadhesive polymer
    »ýü°áÇÕ¼º°íºÐÀÚ
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ
  • hydration polymer
    ¼öÈ­ÁßÇÕü
  • polymer molecule
    ÁßÇÕüºÐÀÚ
  • polymer
    秂͟
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fibrin
    ¼¶À¯¼Ò(àéë«áÈ)
  • Fibrin-stabilizing factor
    ¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ(¡­äÌïÒì×í­)
  • glomerulosclerosis,fibrin cap
    ¼¶À¯¼Òµ¤°³
  • gluten fibrin
    ±Û·çÅÙ¼¶À¯¼Ò.
  • addition polymer
    ºÎ°¡ÁßÇÕ¹°(¡­ñìùêÚª).
  • graft polymer
    À̽ÄÁßÇÕü.
  • high polymer
    °íÁßÇÕü(ÍÔñìùêô÷).
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ(ÍÔÝÂí­ûùùÊ).
  • polymer
    Æú¸®¸Ó, ÁßÇÕü(ñìùêô÷).
  • polymer
    秂͟
  • polymer molecule
    ÁßÇÕüºÐÀÚ(ñìùêô÷ÝÂí­).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • addition polymer
    ºÎ°¡ÁßÇÕ¹°(¡­ñìùêÚª).
  • bioadhesive polymer
    »ýü°áÇÕ¼º °íºÐÀÚ(ÍÔÝÂí­).
  • graft polymer
    À̽ÄÁßÇÕü.
  • high polymer
    °íÁßÇÕü(ÍÔñìùêô÷).
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ(ÍÔÝÂí­ûùùÊ).
  • hydration polymer
    ¼öÈ­ÁßÇÕü.
  • linear polymer
    ¼±»óÁßÇÕü(¡­ñìùêô÷).
  • lyophile polymer
    Ä£¾×¼º ÁßÇÕü(öÑäûàõñìùêô÷).
  • polymer
    Æú¸®¸Ó, ÁßÇÕü(ñìùêô÷).
  • polymer
    秂͟
  • polymer molecule
    ÁßÇÕüºÐÀÚ(ñìùêô÷ÝÂí­).
  • carmine fibrin
    Ä«¸£¹Î¼¶À¯¼Ò(¡­àéë«áÈ).
  • crystal fibrin
    °áÁ¤¼¶À¯¼Ò, ¼öÁ¤Ã¼¼¶À¯¼Ò(¡­àéë«áÈ).
  • fibrin
    ¼¶À¯¼Ò(àéë«áÈ), È­À̺기.
  • fibrin abnormality
    ¼¶À¯¼ÒÀÌ»ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrin polymer
    ¼¶À¯¼Ò ÁßÇÕü(àéë«áÈñìùêô÷)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrin
    ¼¶À¯¼Ò(àéë«áÈ)
  • fibrin monomer
    ¼¶À¯¼Ò ´Ü·®Ã¼(àéë«áÈÓ¤Õáô÷)
  • fibrin-stabilizing factor
    ¼¶À¯¼Ò ¾ÈÁ¤È­ÀÎÀÚ(àéë«áÈäÌïÒûùì×í­)
  • insoluble fibrin
    ºÒ¿ë¼º(ÝÕéÁàõ) È­À̺기
  • soluble fibrin
    "°¡¿ë(ʦéÁ)ÇǺ기, °¡¿ë ¼¶À¯¼Ò(ʦéÁàéë«áÈ)"
  • addition polymer
    ºÎ°¡ÁßÇÕü(ݾʥñìùêô÷)
  • aperiodic polymer
    ºñÁÖ±âÀû(ÞªñÎÑ¢îÜ) ÁßÇÕü(ñìùêô÷)
  • atactic polymer
    ¾ÆÅ¹Æ®ÁßÇÕü(ñìùêô÷)
  • branched polymer
    ºÐÁöÁßÇÕü(ÝÂò«ñìùêô÷)
  • chain-growth polymer
    »ç½½½ÅÀå(ãßíþ)ÁßÇÕü(ñìùêô÷)
  • condensation polymer
    ÃàÇÕ ÁßÇÕü(õêùêñìùêô÷)
  • flexible polymer
    °¡º¯ ÁßÇÕü(ʦܨñìùêô÷)
  • isotactic polymer
    µ¿ÀϹ迭 ÁßÇÕü(ÔÒìéÛÕÖªñìùêô÷)
  • linear polymer
    ¼±ÇüÁßÇÕü(àÊû¡ñìùêô÷)
  • periodic polymer
    ÁÖ±â ÁßÇÕü(ñÎÑ¢ñìùêô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polymer
    Æú¸®¸Ó, ÁßÇÕü
  • fibrin
    ¼¶À¯¼Ò, È­À̺기
  • fibrin plug
    È­À̺기ÀüÀÚ, ¼¶À¯¼ÒÀü
  • fibrin sealant
    ¼¶À¯¼Ò¹ÐÆóÁ¦(¹ÐºÀÁ¦)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SFC soluble fibrin complex; soluble fibrin-fibrinogen complex; spinal fluid count
DHP dehydrogenated polymer; dihydroprogesterone; 1,4-dihydropyridine
poly-IC, poly-I:C copolymer of polyinosinic and polycytidylic acids; synthetic RNA polymer
FSF Fibrin Stabilizing Factor(Factor XIII)
FSP Fibrin Split Product
  = FDPs
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IPN Interpenetrating polymer network
MIP Molecularly imprinted polymer
GP glucose polymer
FDP Fibrin Degradation Product
FbDP Fibrin Degradation Products
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • crystal fibrin
    °áÁ¤ ¼¶À¯¼Ò, ¼öÁ¤Ã¼ ¼¶À¯¼Ò
  • fibrin bodies of pleura
    È丷 ¼¶À¯ ¼Òü
    È丷°­ ±âÀúºÎ±Ù¿¡ ÀÖ´Â °¡µ¿¼º ¶Ç´Â Á¡Âø¼º, ±¸»ó, µ¿Áú¼º, ±×¸®°í ÇѰ谡 ¸íÈ®ÇÑ À¯¹éü·Î¼­, È丷 »ïÃâ¾×, ±âÈä ¶Ç´Â Ç÷±âÈäÁõ¿¡¼­ ÀÌÂ÷ÀûÀ¸·Î ¹ß»ýÇÑ´Ù.
  • fibrin plug
    È­À̺기 ÀüÀÚ, ¼¶À¯¼ÒÀü
  • fibrin thrombus
    È­À̺êÁø Ç÷Àü
  • bioadhesive polymer
    »ýü°áÇÕ¼º °íºÐÀÚ
  • D-amino acid polymer
    D-¾Æ¹Ì³ë»ê ÁßÇÕü
    D-amino »ê¿¡¼­ ÇÕ¼ºÇÏ¿© ¸¸µé¾îÁø Ç׿ø¼ºÀÌ °­ÇÑ ÆéŸÀ̵å, ¶Ç´Â Æú¸® ÆéŸÀ̵å.
  • insoluble polymer
    ºÒ¿ë¼º ÁßÇÕÁ¦
  • linear polymer
    ¼±»ó ÁßÇÕü
    ºÐÀÚÀÇ Çü»óÀÌ »ç»óÀÎ ÁßÇÕ¹°·Î ºÐÁöÇÑ ÁßÇÕ¹°, ȤÀº °¡°øµÈ ÁßÇÕ¹°¿¡ ´ëºñµÈ´Ù´Â ¶æ.
  • polymer
    ÁßÇÕü, ·¹Áø ºÐ¸»
    1. ´õ ÀÛÀº ´Ü·®Ã¼ÀÇ ¹Ýº¹¿¡ ÀÇÇØ Å« À¯±â ºÐÀÚü¸¦ Çü¼ºÇÏ´Â È­ÇÐÀûÀÎ È­ÇÕ¹°. 2. ´Ü·®Ã¼°¡ ¹Ýº¹ °áÇÕÇÏ¿© »ý¼ºµÈ °íºÐÀÚ È­ÇÕ¹°.
  • polymer tag
    ÁßÇÕü µ¹Ãâ¹°, ÁßÇÕü µ¹±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
addition polymer <chemistry> A polymer which is formed from the fusion of two monomers which join completely without losing any small molecules.
(15 Jan 1998)
condensation polymer <chemistry> The kind of polymer that is formed by the combination of monomers and the release of a small molecules at the point where monomers are joined.
(05 Jan 1998)
polymer <chemistry> A macromolecule made of repeating (monomer) units or protomers.
(18 Nov 1997)
polymer fume fever An occupational disease marked by fever, pain in the chest, and cough caused by the inhalation of fumes given off by a plastic, polytetrafluorethylene, when heated.
(05 Mar 2000)
human fibrin foam A dry artificial sponge of human fibrin prepared by clotting with thrombin a foam of a solution of human fibrinogen; the clotted foam is dried from the frozen state and heated; used as a topical anticoagulant.
(05 Mar 2000)
fibrin <protein> The insoluble protein formed from fibrinogen by the proteolytic action of thrombin during normal clotting of blood. Fibrin forms the essential portion of the blood clot.
(12 Nov 1997)
fibrin calculus A urinary calculus formed largely from fibrinogen in blood.
(05 Mar 2000)
fibrin degradation products <haematology, investigation> A test that measures fibrin degradation products which result from the dissolution of a blood clot.
Normal value is less than 10 mcg/ml (micrograms per millilitre).
They may be increased in conditions such as burns, placental abruption, heart disease, DIC, after massive blood transfusion, hypoxia, intrauterine foetal death, portacaval shunt, leukaemia, transfusion reaction, transplant rejection, sepsis, renal failure and preeclampsia.
Acronym: FDP
(23 Sep 2002)
fibrin destabilase <enzyme> Hydrolyses the epsilon-(gamma-glutamyl)-lysine bonds of stabilised fibrin
Pharmacological action: fibrinolytic agents
Registry number: EC 3.4.99.-
Synonym: destabilase
(26 Jun 1999)
fibrin fibrinogen degradation products <chemical> Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. Fdp and their complexes profoundly impair the haemostatic process and are a major cause of haemorrhage in intravascular coagulation and fibrinolysis.
Pharmacological action: antithrombins.
(12 Dec 1998)
fibrin foam <chemical> A dry artificial sterile sponge of fibrin prepared by clotting with thrombin a foam or solution of fibrinogen. It is used in conjunction with thrombin as a haemostatic in surgery at sites where bleeding cannot be controlled by more common methods.
Pharmacological action: haemostatics, tissue adhesives.
(12 Dec 1998)
fibrinogen-fibrin conversion syndrome <syndrome> A syndrome characterised by hypofibrinogenaemia with incoagulable blood; it may be seen in abruptio placentae, prolonged retention of a dead foetus in an Rh-isosensitised mother, haemolytic blood reactions, bilateral renal cortical necrosis, and cases of trauma.
(05 Mar 2000)
fibrin-stabilizing factor <chemical> Fibrin stabilizing factor. It is a glycoprotein activated by thrombin in the presence of calcium to form factor xiiia. Factor xiii is found evenly distributed between plasma and platelets. Its function is to stabilise the formation of the fibrin polymer (clot) which culminates the coagulation cascade.
Chemical name: Blood-coagulation factor XIII
(12 Dec 1998)
fibrin thrombus A thrombus formed by repeated deposits of fibrin from the circulating blood; it usually does not completely occlude the vessel.
(05 Mar 2000)
fibrin tissue adhesive <chemical> An autologous or commercial tissue adhesive containing fibrinogen and thrombin. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, factor viii, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agent such as aprotinin. Mixing of the two components promotes clotting and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, haemostasis, and wound healing.
Pharmacological action: haemostatics, tissue adhesives.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrin
    ¼¶À¯¼Ò
  • high polymer
    °íºÐÀÚ(°Å´ëºÐÀÚ) ¹°Áú
  • high polymer chemistry
    °íºÐÀÚ(È­)ÇÐÀÇ;°­·ÂÇÑ;(±¤ÇÐ ±â±â°¡)¹èÀ²ÀÌ ³ôÀº;Á¤·ÂÀûÀÎ
  • polymer
    秂͟
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á